Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Raises EPS, Revenue Guidance as Phadia Purchase Closes

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today raised its adjusted EPS and revenues guidance for full-year 2011 following the completion of its purchase of specialty diagnostics firm Phadia.

Thermo Fisher announced that its $3.5 billion purchase of the firm had closed and said that the acquisition is expected to contribute $.07 to full-year EPS, a $.01 increase from an original estimate of $.06, excluding restructuring, amortization of acquisition-related intangible assets, and other gains and costs.

As a result, it raised adjusted EPS guidance to a new range of between $4.15 and $4.25, which would represent a 20 percent to 23 percent increase over 2010 EPS. During its recent second-quarter earnings release, Thermo Fisher had given adjusted EPS guidance of between $4.08 and $4.18.

Phadia is also expected to contribute $190 million in revenues to Thermo Fisher for the year, and as a result the company raised its revenue guidance to a new range of $11.79 billion to $11.89 billion, which would represent around 12 percent growth over 2010.

Thermo Fisher had given guidance of between $11.60 billion to $11.70 billion last month.

Based in Uppsala, Sweden, Phadia has 1,500 employees worldwide and generated €367 ($529.5 million) in revenues in 2010. Phadia will become part of Thermo Fisher's Specialty Diagnostics business.

Following Thermo Fisher's announcement, Jon Wood of investment bank Jefferies raised his full-year 2011 EPS and revenue estimates for the company to $4.22 and $11.9 billion, respectively. He previously had estimated EPS of $4.15 on revenues of $11.7 billion.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.